Healthcare research from Bristol Myers Squibb, page 4
A filtered view. Show the full list.
Refine
Listings
-
ArticleAdvances in therapy
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleDermatology and therapy
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleDermatology and therapy
Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in China
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleDermatology and therapy
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleCardiology and therapy
Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom
Listed An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleNeurology and therapy
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in the United States
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, University of Pennsylvania. Affiliation source
Clinical careAdded
-
ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ReviewDrug safety
Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleDrug safety
Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ReviewPharmacoEconomics
Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticlePharmacoEconomics
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticleRheumatology and therapy
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticlePharmacoEconomics - open
Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticlePharmacoEconomics - open
United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ReviewPharmacoEconomics - open
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma
Listed An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportAmerican heart journal
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, University of Pennsylvania. Affiliation source
Clinical careAdded
-
ArticleAmerican heart journal plus : cardiology research and practice
Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticleThe American journal of cardiology
Proteomic Correlates of the Urinary Protein/Creatinine Ratio in Heart Failure With Preserved Ejection Fraction
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source
Disease researchAdded
-
Clinical trial reportThe American journal of medicine
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleBioorganic & medicinal chemistry letters
Structure-activity relationship (SAR) studies on substituted N-(pyridin-3-yl)-2-amino-isonicotinamides as highly potent and selective glycogen synthase kinase-3 (GSK-3) inhibitors
Listed An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
Clinical trial reportBreast (Edinburgh, Scotland)
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleCells & development
Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Princeton University. Affiliation source
Disease researchAdded
-
ArticleClinical genitourinary cancer
Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded